These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18288251)

  • 21. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.
    Chan KC
    Chin J Cancer; 2014 Dec; 33(12):598-603. PubMed ID: 25418194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of microRNAs in nasopharyngeal carcinoma.
    Tan G; Tang X; Tang F
    Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China.
    Zheng X; Yan L; Nilsson B; Eklund G; Drettner B
    Acta Oncol; 1994; 33(8):867-72. PubMed ID: 7818917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasopharyngeal carcinoma: understanding its molecular biology at a fine scale.
    Paul P; Deka H; Malakar AK; Halder B; Chakraborty S
    Eur J Cancer Prev; 2018 Jan; 27(1):33-41. PubMed ID: 27748661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Tsang CM; Tsao SW
    Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
    Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
    EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
    Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
    Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.
    Li L; Zhang Y; Fan Y; Sun K; Su X; Du Z; Tsao SW; Loh TK; Sun H; Chan AT; Zeng YX; Chan WY; Chan FK; Tao Q
    Epigenomics; 2015; 7(2):155-73. PubMed ID: 25479246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma.
    Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
    Med Microbiol Immunol; 2003 Aug; 192(3):141-4. PubMed ID: 12920589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population.
    Edreis A; Mohamed MA; Mohamed NS; Siddig EE
    Infect Agent Cancer; 2016; 11():55. PubMed ID: 27833652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs.
    Lei F; Lei T; Huang Y; Yang M; Liao M; Huang W
    Curr Mol Pharmacol; 2020; 13(3):192-205. PubMed ID: 31880267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
    Fung SY; Lam JW; Chan KC
    Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.
    Lung ML; Cheung AK; Ko JM; Lung HL; Cheng Y; Dai W
    Chin J Cancer; 2014 Nov; 33(11):556-68. PubMed ID: 25367335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
    Cho WC
    Mol Cancer; 2007 Jan; 6():1. PubMed ID: 17199893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
    Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
    Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction.
    Tung YC; Lin KH; Chu PY; Hsu CC; Kuo WR
    Kaohsiung J Med Sci; 1999 May; 15(5):256-62. PubMed ID: 10375867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.